Study of the Fed-Fast Pharmocokinetics and Bioequivalance of 300mg Capsules of Droxidopa

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

July 31, 2010

Primary Completion Date

August 31, 2010

Study Completion Date

August 31, 2010

Conditions
Symptomatic Neurogenic Orthostatic Hypotension
Interventions
DRUG

Droxidopa

One capsule containing 300 mg droxidopa, given once

DRUG

Droxidopa

3 capsules each containing 100 mg droxidopa, give 3 times at 4 hour intervals

DRUG

Droxidopa

3 capsules each containing 100 mg droxidopa, given once

Trial Locations (1)

58104

Cetero Research, Fargo

Sponsors
All Listed Sponsors
lead

Chelsea Therapeutics

INDUSTRY